CA-102

N/A

Report date: 2024/12/12 10:34:03

Base Information

Drug NameCA-102
Drug Alias NameCA-102CA102
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsSignal transducer and activator of transcription 3 inhibitors
TargetsSerine/threonine-protein kinase mTORSignal transducer and activator of transcription 3
Therapy Area/IndicationsUrinary Bladder NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCurigin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCurigin Co Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A